Early research (Phase 1)Not Yet RecruitingNCT07260162
What this trial is testing
Evaluation of Safety, Tolerability and Response of ATO-101™ in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU)
Who this might be right for
Bladder Cancer
Institut Cancerologie de l'Ouest 24